Drug Approval | April 21, 2025
FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
Vepdegestrant is the first and only PROteolysis TArgeting Chimera (PROTAC) evaluated in a Phase 3 clinical trial and the first to show benefit in patients with breast cancer
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
ANVIMO will be available in dosages of 240 mg and 480 mg
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Subscribe To Our Newsletter & Stay Updated
